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Abstract
A melanocyte malignant transformation model was developed in our laboratory, in which different melanoma cell lines
were obtained after submitting the non-tumorigenic melanocyte lineage melan-a to sequential cycles of anchorage
impediment. Our group has already showed that increased superoxide level leads to global DNA hypermemethylation as
well increased Dnmt1 expression few hours after melanocyte anchorage blockade. Here, we showed that Ras/Rac1/ERK
signaling pathway is activated in melanocytes submitted to anchorage impediment, regulating superoxide levels, global
DNA methylation, and Dnmt1 expression. Interestingly, Ras and Rac1 activation is not related to codon mutations, but
instead regulated by superoxide. Moreover, the malignant transformation was drastically compromised when melan-a
melanocytes were submitted to sequential cycles of anchorage blockage in the presence of a superoxide scavenger. This
aberrant signaling pathway associated with a sustained stressful condition, which might be similar to conditions such as UV
radiation and inflammation, seems to be an early step in malignant transformation and to contribute to an epigenetic
reprogramming and the melanoma development.
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Introduction
Evidence has linked chronic cellular stress with increased risk
for many diseases, including cancer [1]. In melanomas, for
example, ultraviolet radiation and persistent inflammation lead to
increased reactive oxygen species (ROS) generation and are risk
factors for melanoma development [2,3,4]. ROS are important
regulators of cell signaling, modulating biological processes as
proliferation, apoptosis and differentiation. However, misbalance
between ROS production and cellular antioxidant system can
result in oxidative stress, which may cause damage to DNA,
protein and cellular components. Additionally, some studies have
also shown that altered ROS levels could affect epigenetic
mechanisms [5,6,7]. Epigenetic mechanisms promote alterations
in gene expression without changes in DNA sequence and
comprise DNA methylation, histone modifications and variants,
and nucleosome remodeling. These mechanisms are essential to
normal development and tissue specific gene expression and their
disruption could contribute to cancer development [8,9]. The
most studied epigenetic modification in mammals is the DNA
methylation at the 5 position of cytosine residue within cytosine-
guanine dinucleotides (CpG), resulting in the formation of 5-
methylcytosine [10]. Promoter hypermethylation is linked with
gene expression inactivation and results from the activity of a
family of DNA methyltransferases (DNMTs), specifically DNMT1,
3A and 3B [11]. Besides epigenetic mechanisms have been heavily
studied in cancer, until now it is not known which factors initiate
abnormal DNA methylation. In this manner, some authors have
proposed that repetitive stress conditions could be a factor driving
aberrant epigenetic modifications in cancer development [12,13].
To better understand the relationship among repetitive injury,
epigenetic mechanisms and malignant transformation, our group
developed an in vitro melanocyte malignant transformation model
based on the sustained stress condition exposure. In this model,
different melanoma cell lines were obtained after submitting a
non-tumorigenic melanocyte lineage, melan-a, to sequential cycles
of adhesion impediment [14,15,16]. This adhesion impediment
was characterized as a stressful condition to melan-a cell line since
increased amounts of ROS are produced during this process
[5,17]. Moreover, our group has already showed that global DNA
methylation and Dnmt1 protein level increase few hours after
melan-a anchorage blockade. Interestingly, this increase is related
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with increased levels of superoxide anion produced during this
condition [6]. Then, next step was to understand how oxidative
stress would be linked to Dnmt1 regulation. Would it be through
an oncogene signaling? Genes required to constrain tumor
development are often inactivated by epigenetic marks, such as
hypermethylation of their promoters [18]. However, it is not
known whether this silencing occurs by random acquisition of
epigenetic marks that confer selective advantages for growth or by
activation of specific pathways initiated by an oncogene. Evidences
suggest, for example, that repression of tumor suppressor genes
linked to DNA methylation is regulated by Ras, an important
oncogene [19,20,21], known as a gene driving melanoma
progression [22,23]. In this way, the aim of the present work
was to understand how superoxide anion could change DNA
methylation levels and identify the cellular signaling pathways
involved. Here we showed that Ras/Rac1/MEK/ERK signaling
pathway is regulated by and regulates superoxide anion produc-
tion during melan-a anchorage blockade. The activation of this
particular signaling pathway culminates in increased Dnmt1
expression and global DNA methylation, which in turn may
confer selective advantages for cells submitted to a stressful
environment.
Results
Scavenging Superoxide Anion Decreases Global DNA
Methylation and Dnmt1 Expression
We have previously shown that sequential cycles of melanocyte
anchorage impediment result in malignant transformation [16].
This process is a stressful situation for cells and during the first
hours of cell-matrix interaction loss, increased superoxide anion
and nitric oxide levels, as well alterations in Dnmt1 expression and
global DNA methylation were observed [5]. It was also shown that
both L-NAME (NOS inhibitor) and N-acetylcysteine (antioxidant)
treatment abrogate global DNA methylation increase and Dnmt1
expression observed in melan-a melanocyte lineage submitted to
this stressful condition. Surprisingly, L-NAME was shown to
decrease superoxide anion but not nitric oxide levels [5,17]. To
elucidate the superoxide anion involvement in the epigenetic
alterations found, melan-a cell line was treated with the SOD
mimetic Mn(III)TBAP, a superoxide anion scavenger, during
anchorage impediment. Scavenging superoxide anion (Figure 1,
A and B) results in decrease of global DNA methylation
(Figure 1C), as well in Dnmt1 protein (Figure 1D) and mRNA
(Figure 1E) level. The reduction of superoxide anion levels in
melan-a cells submitted to anchorage blockade in the presence of
Mn(III)TBAP was confirmed by both DHE staining (Figure 1A)
and luminescence using coelenterazine (Figure 1B). These data
show that superoxide level increases during melanocyte anchorage
blockade, leading to increased Dnmt1 expression and global DNA
methylation level (Figure 1F).
Activation of Ras Signaling Pathway is Associated with
Increase in Dnmt1 Protein Level and Global DNA
Methylation
Ras signaling pathway is activated in many tumors, including
melanomas where it is found frequently mutated [24], and
regulates critical events during malignant transformation and
progression, as proliferation, apoptosis and drug resistance
[25,26,27]. As mentioned before, it was demonstrated that
modulation of various cellular processes by Ras protein depends
on DNA methylation of target genes [20,28]. Melan-a melanocyte
lineage submitted to anchorage blockade shows Ras activation
after 30 minutes (Figure 2A). However, no codon mutation at 1st
and 2nd exons (where mutations frequently occurs) was found in
melan-a cell line (data not shown). Treating melan-a cell line
submitted to anchorage impediment for 3 hours with FTI
(farnesyltransferase inhibitor and Ras inhibitor) abrogates the
increase in Dnmt1 protein level (Figure 2B) and restricts global
DNA hypermethylation (Figure 2C), pointing to the involvement
of Ras signaling in the alteration of methylation patterns during
early events involved in malignant transformation associated with
sustained stress (Figure 2D).
Rac1 and Ras, Considered Driver Genes in Melanomas,
are Activated during Melanocyte Anchorage Blockade,
and Regulate and are Modulated by Superoxide Anion
Previous data from our group identified uncoupled endothelial
nitric oxide synthase as one of the superoxide anion sources during
anchorage impediment [17]. Here, NADPH oxidase was identi-
fied as another source of superoxide anion in melan-a melanocytes
submitted to anchorage restriction, since NSC23766 (RAC1
inhibitor) abrogated superoxide levels (Figure 3A). Rac1, a small
Rho GTPase, is a NADPH oxidase cytosolic component that is
recruited to membrane after activation by Ras [29]. Increased
Rac1 protein level in membrane-enriched extracts was observed in
melan-a melanocytes submitted to adhesion blockade for 30
minutes (Figure 3B and E). This increase was inhibited by FTI
showing that activation and translocation of Rac1 to membrane is
downstream to Ras (Figure 3E). Moreover, the recruitment of
Rac1 to membrane was also inhibited in the presence of
superoxide scavenger Mn(III)TBAP, indicating a feedback regu-
lation mechanism (Figure 3B). Recently, two independent
groups demonstrated that Rac1 is the third driver gene more
frequently mutated in melanomas after Ras and B-Raf [22,23].
Nevertheless, there were no point mutations in the whole Rac1
translated sequence (data not shown), indicating that its activation
is by another mechanism. Melan-a melanocytes submitted to
anchorage blockade in the presence of FTI showed decreased
superoxide anion levels (Figure 3, C and D), indicating that
activated Ras signaling pathway in melan-a maintained in
suspension regulates ROS levels. Increased ROS generation is
associated with activation of several oncogenes, including Ras,
acting as second messengers and modulating transduction
pathways [30,31]. In order to investigate if superoxide anion
regulates Ras activation, melan-a cells were treated with superox-
ide scavenger Mn(III)TBAP and submitted to anchorage blockade
for 30 minutes, when Ras activation occurs. Figure 3F shows that
superoxide anion depletion inhibited Ras activation, suggesting a
feedback regulatory mechanism (Figure 3F).
ERK Activation Downstream to Ras Induces Increased
Dnmt1 Protein Expression during Anchorage Blockade
The small GTP-binding protein Ras regulates activation of
several signaling pathways including Raf/MEK/ERK [32]. ERK
activation was observed 30 minutes after melan-a anchorage
blockade (data not shown) and maintained until 3 hours in this
condition (Figure 4A). ERK activation was abrogated using FTI,
confirming that ERK activation is downstream to Ras, and was
inhibited using U0126, a specific MEK inhibitor (Figure 4A).
ERK is downstream to Ras signaling pathway and its participation
in epigenetic regulation was demonstrated by other authors [33].
Then, we next examined the effect of ERK inhibition on global
DNA methylation and Dnmt1 protein level during melanocyte
anchorage blockage. Our results showed that treatment with ERK
inhibitor abrogated significantly the increase in Dnmt1 protein
level observed during melan-a anchorage impediment
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(Figure 4B). PI3K-AKT signaling pathway can also be regulated
by Ras activation [34]. This pathway was also activated in
melanocyte cells submitted to anchorage blockade (data not
shown). However, AKT inhibition was not able to abrogate either
the increase in Dnmt1 protein level and superoxide anion level
during loss of cell-matrix interactions (Figure S1). These data
Figure 1. Scavenging superoxide anion abrogates global DNA hypermetylation and increased Dnmt1 levels during melan-a
anchorage impediment. Superoxide anion levels was determined by flow cytometry using DHE (A) or by luminescence assay using coelenterazine
(B) in melan-a melanocytes adhered (D0) and submitted to anchorage blockade for 3 h (D3 h), treated or not (NT) with 50 mM superoxide scavenger
Mn(III)TBAP. C. The total amount of 5-methylcytosine (5 mC) was determined in the same cells by flow cytometry using a specific antibody. D. Dnmt1
protein expression was analyzed by Western blot in the same conditions. E. Dnmt1 transcript level was determined by real time PCR. F. These data
show that melanocyte deadhesion leads to superoxide production, which is related to increased Dnmt1 expression and global DNA
hypermethylation. For statistical analysis, a non-paired non-parametric Student’s t-test was used to analyze differences between the means using
GraphPad PrismH version 4 for Windows. The significance level was established at. *p,0.05; **p,0.01; ***p,0.001.
doi:10.1371/journal.pone.0081937.g001
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indicate that melanocyte anchorage blockade leads to ERK
activation downstream to Ras, which results in the increase of
Dnmt1 protein level (Figure 4C).
ERK Signaling Pathway is Regulated by Superoxide Anion
in a Feedback Mechanism
Several studies have showed the involvement of ERK activation
in reactive oxygen species production [35,36]. Then, to determine
if ERK signaling pathway regulates superoxide production during
anchorage blockade, melan-a cell line was treated with U0126
during adhesion impediment and superoxide anion levels were
evaluated using DHE or coelenterazine. Figure 5 (A and B) shows
decrease in superoxide generation after inhibition of ERK
activation. ERK activation seems to be downstream to Rac1
membrane translocation and superoxide anion production, since
NSC, a Rac1 inhibitor, abrogated ERK phosphorylation
(Figure 5C). Additionally, melan-a cell line treated with
superoxide scavenger Mn(III)TBAP during adhesion impediment
showed inhibition of ERK phosphorylation (Figure 5D), indicat-
ing the role of superoxide anion in ERK activation and suggesting
a feedback mechanism between ERK and superoxide anion.
Abrogating Superoxide Anion during Sequential Cycles
of Anchorage Restriction Results in Clones with Reduced
Cell Proliferation and Clonogenicity and Increases the
Time Required to Malignant Conversion
After inappropriate attachment to extracellular matrix, super-
oxide anion level increases in melan-a melanocyte lineage [5,17],
fibroblasts, endothelial and epithelial cells [37,38]. Several studies
have shown the fundamental role of superoxide anion in cell
survival and anoikis resistance through the modulation of different
signaling pathways [39,40]. In this way, we performed the
sequential cycles of anchorage blockade in presence of superoxide
scavenger Mn(III)TBAP. We observed an increased latency time
for the establishment of clones in the presence of superoxide
scavenger after limiting dilution (Table 1). Two weeks after the
last cycle of substrate anchorage impediment, virtually all control
clones (cycles of anchorage impediment in the absence of
Mn(III)TBAP) obtained by limited dilution were viable. Differ-
ently, only six clones obtained after anchorage blockade cycles in
the presence of Mn(III)TBAP were viable. Clones obtained both in
the presence or absence of Mn(III)TBAP were maintained in
culture to observe their behavior. Then, after 60 days in culture,
all control clones were at fourth passage (p4) and three of them,
named C2, C7 and C10, presented altered morphology (spindle
shape) (Figure 6A) as that presented by 4C3+, 4C11+, Tm1 and
Tm5 metastatic melanoma cell lines established by our laboratory
using the same anchorage substrate impediment approach [16].
These clones (C2, C7 and C10) presented high cell proliferation
capacity in vitro, while other three (C3, C6 and C9) apparently had
a senescent-like morphology characterized by increased cell size,
flattened and thin cytoplasmic appearance and slow growth in
culture conditions (Figure 6A). However, C3 and C6 were
maintained in culture for more 34 days (totalizing 94 days), until
16th passage (p16), when they lost senescence-like morphology and
decreased their doubling time. Cell proliferation assays showed
that all control clones, including C9, have higher proliferative rate
when compared with Mn(III)TBAP clones (Figure 6, C and D).
Moreover, clonogenic assays were performed with control and
Mn(III)TBAP clones after 94 days, when control cell clones lost
senescent-like morphology. All control cell lines were able to form
colonies, while none Mn(III)TBAP lineages which have not
escaped from senescence-like phenotype, had this capability
(Figure 6, E and F). In order to test their in vivo growth capacity,
the control clones C2, C7 and C10 (p4), C3 and C6 (p16) were
inoculated in syngeneic mice and were tumorigenic with different
times for tumor development (Table 1). In an opposite way, all
Mn(III)TBAP clones presented senescent-like morphology until
135 days maintained in culture (Figure 6B). Mn2 clone, for
example, altered its morphology at 12th passage, only after 135
days in culture and two clones designated Mn1 (p13) and Mn7
(p17) escaped from senescence after 195 days. However, after this
period Mn3, Mn4 and Mn5 clones have not lost the senescent-like
morphology. Additionally, all Mn(III)TBAP clones were subcuta-
neously injected into syngeneic mice and only clones Mn2 and
Mn7, only after loss their senescent-like morphology, were
tumorigenic.
Discussion
Misbalance between reactive oxygen species production and
antioxidants is believed to cause or contribute to several human
diseases, such as cancer. Another common deregulated process in
tumor cells is DNA methylation, which affects gene expression and
chromatin stability. Many tumor suppressor genes became
hypermethylated in cancer and a currently explanation is the
increased expression of DNMT1 observed in several tumor cell
lines [41,42]. Nevertheless, the factors regulating DNMT1
expression and contributing to the initiation of epigenetic aberrant
modifications are still unknown. Growing evidences support the
link between pathological ROS production and epigenetic
aberrant alterations found in cancer [13,43]. In this work, Ras/
Rac1/ERK pathway was identified as the signaling pathway
involved in the process that culminates in increased superoxide
Figure 2. Ras signaling is activated during melanocyte
anchorage blockade and its inhibition abrogates increased
Dnmt1 protein level and global DNA hypermethylation
observed in this condition. A. Ras activity was evaluated in adhered
(D0) and deadhered melanocytes (D309) B. Dnmt1 protein expression
using whole cell extracts was measured in the same conditions. C. The
5-methylcytosine (5 mC) content was determined by FACS using a
specific antibody in adhered (D0) and deadhered (D3 h) melan-a
melanocytes, treated (FTI) or not (NT) with 12.5 mM farnesyltransferase
inhibitor. D. Melanocyte anchorage impediment results in Ras
activation, which leads to increased Dnmt1 level and global DNA
hypermethylation. **p,0.01.
doi:10.1371/journal.pone.0081937.g002
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anion level, Dnmt1 protein overexpression, increased global DNA
methylation level, and melanocyte malignant transformation.
Normally, cell response to pathological ROS levels activates
numerous intracellular signaling pathways, which in turn regulate
transcriptional changes that allow cells to respond appropriately to
new environment. Several authors have shown that activation of
Ras signaling pathway leads to increased intracellular ROS levels
in different cell lines, such as keratinocytes and epithelial cells
[44,45,46]. Although the above studies implicate Ras signal
transduction in the generation and regulation of intracellular
superoxide anion levels, there are few evidences that Ras can be
also activated by ROS [47,48,49]. In NIH-3T3 fibroblasts, the
constitutively activated isoform of p21Ras, H-Rasv12, increased
superoxide production by Nox1 (NADPH oxidase catalytic
subunit) and was found to be functionally required for cellular
transformation [50]. It was also shown that activated Ras induced
the translocation of NADPH oxidase cytosolic components
(p67phox and Rac) to plasma membrane leading to its activation
Figure 3. Rac1 and Ras, considered driver genes in melanomas, are activated during melanocyte anchorage blockade, and regulate
and are modulated by superoxide anion. A. Melanocytes were submitted to anchorage substrate impediment (D3 h) in the presence or not
(NT) of 100 mM NSC, a Rac1 inhibitor, and superoxide anion levels were evaluated by flow cytometry using DHE. B. Translocation of Rac1 to
membrane was evaluated by Western blot using membrane-enriched extracts in adhered (NT) and deadhered melanocytes, treated or not with
50 mM superoxide scavenger Mn(III)TBAP (Mn). Superoxide anion was determined in adhered (D0) and in melan-a cells submitted to anchorage
blockade for 3 hours (D3 h) in the presence or not (NT) of 12.5 mM FTI by flow cytometry using DHE (C) or by luminescence assay using
coelenterazine at same condition (D). E. Rac1 membrane translocation was evaluated by Western blot in adhered (NT) and deadhered melanocytes,
treated or not with 12.5 mM FTI. F. Ras activity was evaluated in adhered (D0) and deadhered melanocytes (D3 h) treated (Mn) or not (NT) with 50 mM
Mn(III)TBAP. G. Rac1 is activated during deadhesion, contributing to superoxide production and Ras activation. Activated Ras modulates Rac1
activation and superoxide anion level in a feedback mechanism. For statistical analysis, a non-paired non-parametric Student’s t-test was used to
analyze differences between the means using GraphPad PrismH version 4 for Windows. The significance level was established at. *p,0.05; **p,0.01;
***p,0.001.
doi:10.1371/journal.pone.0081937.g003
Superoxide Modulates Dnmt1 via Ras/Rac1 Pathway
PLOS ONE | www.plosone.org 5 December 2013 | Volume 8 | Issue 12 | e81937
[51,52]. NADPH oxidases are a family of five-subunit enzymes
that transfers electrons from NADPH to molecular oxygen to
produce superoxide and its metabolite, hydrogen peroxide. In fact,
we found increased Rac1 translocation to membrane (Figure 3,
B and E) and Ras activation (Figure 2A) during melan-a
anchorage impediment and part of superoxide generated by this
process seems to come from NADPH oxidase, since NSC, a Rac1
inhibitor, decreased superoxide levels (Figure 3A). Additionally,
superoxide production showed to be affected by Ras-ERK
signaling during loss of cell-matrix attachment, once FTI and
U0126 treatment abrogated its production (Figures 3C, 3D,
5A and 5B). In the other hand, superoxide anion also affects Ras-
ERK pathway since its depletion impaired their activation during
anchorage restriction (Figures 3F and 5C and 5D). It was shown
that oxidants as H2O2 can direct modify H-Ras Cys118, which
resides on a loop close to guanine nucleotide, affecting GTP/GDP
exchange and increasing GTP loading [53]. It was demonstrated a
landscape of driver coding mutations associated with UV-light-
induced damage in human melanoma, which include oncogenes
as Ras, B-Raf and Rac1 [22]. Here we show that Ras and Rac1,
oncogenes that driver deregulated process such as proliferation
and apoptosis in melanoma development, can be activated by
reactive oxygen species without any known mutation. Oxidative
stress-induced ERK1/2 activation is reported in different cell types
[54,55]. Activation of ERK by ROS plays a critical role in
apoptosis protection, since antioxidants decrease ERK phosphor-
ylation and induce tumor cell death [37].
Besides modulation of signal transduction, redox-dependent
transcriptional regulation occurs through reversible oxidation of
numerous proteins, including tyrosine phosphatases, tyrosine
kinases and transcription factors, for example, the redox-depen-
dent modification of transcription factors as Activator Protein-1
(AP-1) [56]. AP-1 results from heretodimerization of c-Fos and c-
Jun proteins, and this complex is important for proper induction of
Figure 4. ERK activation downstream to Ras induces increased
Dnmt1 protein expression during anchorage blockade. A. ERK
activation was analyzed by Western blotting in adhered (D0) and
deadhered (D3 h) melanocytes treated or not (NT) with 12.5 mM FTI or
15 mM U0126. B. Dnmt1 protein expression using whole cell extract was
measured in adhered (D0) and deadhered (D3 h) melanocytes treated
or not (NT) with 15 mM U0126. C. Anchorage impediment leads to Ras/
ERK activation, which results in increased Dnmt1 protein level.
doi:10.1371/journal.pone.0081937.g004
Figure 5. ERK signaling pathway is regulated by superoxide anion in a feedback mechanism. Superoxide anion levels was analyzed in
adhered (D0) and deadhered (D3 h) melanocytes in the presence or not of 15 mM U0126 by flow cytometry using DHE (A) or by luminescence assay
using coelenterazine (B). ERK activation was analyzed by Western blotting in adhered (D0) and deadhered (D3 h) melanocytes treated or not (NT)
with 100 mM Rac1 inhibitor NSC (C) or 50 mM Mn(III)TBAP (D) E. ERK activation induced by anchorage impediment is downstream of Rac1 activation
and superoxide production. *p,0.05; **p,0.01; ***p,0.001; ****p,0.0001.
doi:10.1371/journal.pone.0081937.g005
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Figure 6. Abrogating superoxide anion during sequential cycles of anchorage restriction results in clones with reduced cell
proliferation and clonogenicity and increases the time required to malignant conversion. Melan-a melanocytes were submitted to
sequential cycles of anchorage impediment in the presence (Mn clones) or not (control clones) of 50 mM Mn(III)TBAP. Almost control clones showed
spindle morphology (A) whereas Mn clones senescent-like aspect (B). Cell proliferation was analyzed by MTT assay in control (C) and Mn clones (D).
Superoxide Modulates Dnmt1 via Ras/Rac1 Pathway
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many genes involved in cellular damage protection and repair
against ROS damage. Additionally, AP1 may be responsible for
Dnmt1 gene activation [57]. Moreover, cells that overexpress c-Fos
showed increased Dnmt1expression and multiple drugs resistance
phenotype, including drugs inducing oxidative stress [58]. In
concordance with this, we observed that superoxide scavenger
abrogated the increase in Dnmt1 mRNA and protein level
(Figure 1, D and E) and global DNA hypermethylation
(Figure 1C) in melanocytes submitted to anchorage restriction.
Additionally, increased amounts of phosphorylated c-Jun was
observed at nucleus in melan-a cells during adhesion impediment
(data not showed), which is related with increased activity and
DNA-binding capability [59]. In this way, alteration in AP-1
transcriptional factor phosphorylation and activity due to super-
oxide anion increase might change Dnmt1 expression and result in
global DNA hypermethylation.
Proper attachment to extracellular matrix is essential to cell
survival and loss of integrin engagement to extracellular matrix in
non-transformed cells results in an apoptotic process namely anoikis
[60]. Anoikis resistance is one of the acquired capabilities of
tumorigenic cells to disseminate. Increased oncogene and
decreased tumor suppressor genes expression can improve
protection from anoikis [61,62]. In this study, melan-a melanocyte
lineage submitted to anchorage blockade presented Ras activation
in the first 30 minutes (Figure 2A) and some authors have
demonstrated that Ras signaling can affect gene expression
through DNA methylation. Downregulation of tumor suppressor
genes as E-cadherin and apoptosis-promoting protein Par-4, for
example, was shown as result of their promoter hypermethylation
induced by Ras [21,63]. Moreover, it was shown that K-Ras-
transformed NIH 3T3 fibroblasts have increased levels of Dnmt1
protein, which were associated with the Fas gene promoter
hypermetylation [19]. Here we showed that FTI (farnesyltransfer-
ase inhibitor) impairs the increase in Dnmt1 protein level
(Figure 2B) and global DNA hypermethylation (Figure 2C)
induced by anchorage restriction. Two of the major signaling
pathways activated by Ras that are related to cancer and to
changes in DNA methylation are PI3K-AKT and MEK-ERK
[33,34]. We rule out PI3K-AKT pathway involvement since its
inhibition by Wortmannin and LY294002 had no effect on
superoxide and Dnmt1 protein levels (Figure S1). In relation to
MEK-ERK signaling pathway, we observed its activation during
melan-a anchorage blockade (Figure 4A) and its inhibition
impaired the increase both in superoxide (Figure 5A and B) and
Dnmt1 protein level (Figure 4B) observed during adhesion
impediment. In this way, Ras/Rac1/ERK pathway activation
observed during loss of cell-matrix contacts may be involved in an
epigenetic reprogramming caused by sustained oxidative stress
condition. This process could then allow cells to adjust to new
stressor environment, enabling them to survive. Supporting such
hypotheses is the fact that several authors have shown increased
superoxide levels after anchorage impediment [37,38] and we
demonstrated that its depletion during this process sensitized
melanocyte and melanoma cells to anoikis [17,37,38]. Further-
more, cell lines obtained by sequential anchorage impediment
cycles presented global and gene-specific epigenetic aberrant
modifications [17]. We have also shown that anchorage imped-
iment cycles performed in the presence of a superoxide scavenger
gave rise to significant diminished number of clones compared to
control after limiting dilution, suggesting that they are less anoikis-
The clonogenic capability of control (E) and Mn clones (F) was evaluated before escape from senescent-like phenotype by plating 200 cells on
60 mm-dishes. After 9 days, the cell number was estimated by measuring the absorbance after lysing the cells stained with Toluidine blue.
doi:10.1371/journal.pone.0081937.g006
Table 1. Characteristics of control and MnTBAP clones.
Before senescent-like
phenotype
After senescent-
like phenotype
Cell lines
Latency time for
senescent-like
phenotype escape
(days)
Latency time for tumor
development (days)*
Clonogenic
capability
Latency time for tumor
development (days)*
Clonogenic
capability
Control clones
CL2 60 13 Yes 13 Yes
CL3 94 Non-tumorigenic ND 60 Yes
CL6 94 Non-tumorigenic ND 18 Yes
CL7 60 15 Yes 15 Yes
CL9 ‘ Non-tumorigenic ND Non-tumorigenic No
CL10 60 15 Yes 15 Yes
MnTBAP clones
Mn1 135 Non-tumorigenic No Non-tumorigenic Yes
Mn2 135 Non-tumorigenic No 15 Yes
Mn3 ‘ Non-tumorigenic No Non-tumorigenic No
Mn4 ‘ Non-tumorigenic No Non-tumorigenic No
Mn5 ‘ Non-tumorigenic No Non-tumorigenic No
Mn7 195 Non-tumorigenic No 16 Yes
*16106 cells subcutaneously inoculated; ND – Not determined; ‘ - Cells that until now have not escaped from senescent-like phenotype.
doi:10.1371/journal.pone.0081937.t001
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resistant. Moreover, these cell lines presented senescent-like
morphology in culture differently of majority of control cell lines,
which were obtained by the same process, but in absence of
superoxide scavenger (Figure 6, A and B). One of senescence
characteristics is that cells become larger, with flattened morphol-
ogy and nucleus centrally located within cytoplasm. Besides that,
senescent cells may be multinucleated and present positive b-Gal
staining, common biomarker for senescence [64]. Although
senescent-like cell lines obtained by adhesion impediment in the
presence of superoxide scavenger present these features for long
period, they can replicate in culture. Indeed there are some reports
about cell lines that have senescent characteristics but replicate in
culture [65]. Cellular senescence is a potent tumor suppressive
mechanism that normally arrests cell proliferation and has been
linked to aging and cellular response to stressful microenvironment
conditions, including oxidative stress [66]. Some works show a
central role of oxidative stress in senescence but they usually study
the effects of hydrogen peroxide or non-selective antioxidants
[67,68]. In contrast, recent findings have showed that ROS
activate signaling pathways and promote cell survival and
longevity [69]. Here we observed specific superoxide effect on
cellular senescent-like phenotype after the stressful condition that
characterizes anchorage impediment since its depletion signifi-
cantly delays senescent output. In this way, anchorage impediment
cycles applied to melan-a melanocytes in an environment in which
superoxide produced is depleted has another effect on cellular
survival and behavior.
In our sustained stress model, Ras/Rac1/ERK signaling
pathway regulates and is regulated by oxidative stress, specifically
by superoxide anion. Besides that, this pathway is related to
alterations in Dnmt1 protein levels and global DNA methylation
(Figure 7). DNA methylation alterations caused by oxidative
stress might change gene expression profile culminating in cellular
phenotype and malignant transformation. It is possible that in
human skin, conditions leading to increased production of ROS,
such as UV radiation and inflammation, if in a sustained way,
could result in epigenetic alterations, which may contribute to the
melanocyte malignant transformation.
Methods
Ethics Statement
All animal work were conducted according to the recommen-
dations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health and were approved by Ethics
Committee of Universidade Federal de Sa˜o Paulo (CEP nu 0219-
07).
Cell Culture, Anchorage Blockade Assay and Cell
Treatments
Melan-a is a non-tumorigenic cell line of pigmented melano-
cytes spontaneously derived from normal epidermal melanoblasts
from embryos of inbred C57BL mice established by Bennett et al
[70] and properly described in an article from Int. J. Cancer in
1987. The cells were cultured in RPMI 1640 pH 6.9 (Gibco,
Carlsbad, CA) supplemented with 5% fetal bovine serum (v/v),
antibiotics (Gibco) and 200 nM of phorbol myristate acetate
(PMA, Sigma-Aldrich, Saint Louis, MO) at 37uC in humidified
atmosphere of 5% CO2 and 95% air. For the anchorage blockade
assay, melan- a cells (105/ml) were cultured in suspension at 37uC
for different times (109, 309 or 3 h) using 50 ml tubes or agarose-
coated dishes.
Adherent cells (D0) or cells submitted to anchorage blockade for
different times (D10’, D30 and D3 h) were treated or not with
50 mM of superoxide anion scavenger Mn(III)tetrakis(4-benzoic
acid)porphyrin chloride (Mn(III)TBAP, Cayman, Ann Harbor,
Michigan), with 12,5 mM of farnesyltransferase inhibitor (FTI, Bio
Mol, Plymouth Meeting, PA), with 15 mM of ERK inhibitor
U0126 (Calbiochem-Merck, Darmstad, Germany), with the PI3-
kinase inhibitors LY294042 (5 mM) and wortmannin (0.5 mM)
(Sigma) or with 100 mM of Rac1 inhibitor NSC23766 (Calbio-
chem-Merck, Darmstad, Germany in RPMI pH6.9 (Gibco)
supplemented with 0.5% bovine serum, antibiotics (Gibco) and
200 nM of PMA (Sigma-Aldrich).
Non-tumorigenic melan-a cell line was also treated or not with
50 mM Mn(III)TBAP for 2 hours and subsequently, 16104 cells
were submitted to sequential cycles of anchorage impediment in
the presence or not of 50 mM Mn(III)TBAP as described [16].
Measurement of Superoxide Anion (O2
.2)
Adherent cells and cells submitted to anchorage blockade for
different times were assayed for superoxide detection using
dihydroethidium (DHE; Molecular Probes, Carlsbad, CA) and
analyzed by flow cytometry (FACScalibur; Becton Dickinson, San
Juan, CA and chemiluminescence was assessed immediately in a
luminometer (Softmax Pro;Molecular Devices, Sunnyvale, CA,
USA).
5-Methylcytosine Content Using 5-methylcytosine
Specific Antibody
Global DNA methylation was analyzed by staining cells with a
specific monoclonal antibody against 5-methylcytosine (Oncogene,
La Jolla, CA) as previously described [5] and the data were
analyzed by flow cytometry in a FACScan (Becton Dickinson).
Western Blot
Whole-cell lysates were prepared using RIPA buffer (0.1% SDS
(w/v), 0.5% NP-40 (v/v), 0.5% sodium deoxycholate (w/v),
Figure 7. Stress condition and its relation with Ras/Rac1/MEK/
ERK signaling pathway and epigenetic mechanisms regulation.
Ras/Rac1/MEK/ERK signaling pathway seems to be regulated by and
regulates superoxide anion production during melan-a anchorage
blockade and its activation could be responsible for the high Dnmt1
protein level and changes in global DNA methylation during the loss of
cell adhesion. Anchorage blockade might promote an epigenetic
reprogramming in order to adapt the cells to the new microenviron-
mental condition and contribute to the acquisition of a malignant
phenotype.
doi:10.1371/journal.pone.0081937.g007
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protease and phosphatase inhibitors) and used for Dnmt1 Western
blot. Cytoplasmic protein extracts (150 mM of NaCl, 50 mM of
Tris-HCl, 5 mM of EDTA, Igepal 1% (v/v) and protease and
phosphatase inhibitors) were used for ERK Western blots.
Membrane-enriched protein extracts (HEPES 25 mM, NaCl
150 mM, Igepal 1% (v/v), MgCl2 10 mM, EDTA 1 mM, protease
and phosphatase inhibitors) were used for Rac1 Western blot.
Protein lysates were resolved by SDS-PAGE and transferred onto
PVDF membranes (Bio-Rad, Hercules, CA, USA). Specific
antibodies were used followed by secondary antibody incubations,
signals were visualized by chemoluminescence. The band inten-
sities were measured using Processing and Analysis in Java, ImageJ
1.38b (Wayne Rasband, National Institute of Health, USA,
http://rsb.info.nih.gov/ij/).
Ras Activity Assay
Ras activation was determined using the Ras Activation Kit
from Upstate (Upstate, Temecula, CA) as previously described
[47].
Tumorigenicity Assay
Cells from subconfluent monolayers were harvested after trypsin
treatment, counted, and then suspended in PBS. The clones
derived from sequential cycles of anchorage blockage in the
presence or not of 50 mM Mn(III)TBAP (16106 cells) were
subcutaneously injected in the flank of 6- to 8-week-old C57Bl/6
syngeneic female mice. Animals were kept under 12-hours daylight
cycles, without food restriction, and checked daily for tumor
development. The tumor volume (mm3) was measured using the
formula: d26D/2, where d represents the minimum diameter and
D the maximum diameter. Each experimental group consisted of
at least six animals.
Cells Image Capture
The images were acquired by Olympus CK40/Olympus
Singapore microscope using Image-pro 6.2/Media Cybernetics
softwareH.
Colony Formation Assay
Clones derived from sequential cycles of anchorage blockade in
the presence or not of Mn(III)TBAP were subjected to clonogenic
assay as previously described [71].
DNA Sequencing
For DNA sequencing specific primers were designed for part of
the exons 1 and 2 of H-Ras, K-Ras and N-Ras; and for whole
Rac1 translated sequence (Table S1). The sequencing analysis
was done using GeniousH software.
Real Time PCR
The relative expression level of dnmt1 mRNA was determined
by RT-qPCR in melan-a melanocytes adhered (D0) compared to
those maintained in suspension for 3 hours (D3 h) treated or not
with the superoxide scavenger Mn(III)TBAP (Mn). Dnmt1
oligonucleotides were 59- GTGCCCTGCGTGGAGTCTGT-39
(forward) and 59- GTGGTTGTGCCGGTTCCCAGTG-39 (re-
verse); for PCNA were 59- TCGACACATACCGCTGCG-39
(forward) and 59- TAGAATTTTGGACATGCTGGTGA-39 (re-
verse). To calculate the relative expression, melan-a was used as
the calibrator using the formula RQ=2 -DDCt, where
DDCt=DCtsample2 DCtmelan-a, DCt=Ctdnmt12 CtPCNA.
Statistical Analysis
Non-paired non-parametric Student’s t-test was used to analyze
differences between the means using GraphPad Prism version 4
for Windows (GraphPad, San Diego, CA). The significance level
was established at p,0.05.
Supporting Information
Figure S1 Increased level of Dnmt1 during melanocyte
deadhesion does not involve PI3K-Akt signaling path-
way. Superoxide level was determined by luminescence assay
using coelenterazine in melan-a melanocytes adhered (D0) or
maintained in suspension for 3 h (D3 h), treated or not (NT) with
0.5 mM Wortmannin (Wn) (A) or by flow cytometry using DHE in
melan-a melanocytes adhered (D0) or maintained in suspension
for 3 h (D3 h), treated or not (NT) with 5 mM LY294042 (B).
Dnmt1 protein expression evaluated by Western blot in the same
cells treated or not with 0.5 mMWortmannin (Wn) (C) or not with
5 mM LY294042 (D). ****p,0.0001.
(TIF)
Table S1 Primers used for sequencing.
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